History
Foundation Phase
Recognized for quality excellence worldwide
1980 - 1999
Growth &
Challenge Phase
Stronger competitiveness
through stable production.
2000 - 2008
Global Expansion Phase
Evolved into a global health partner.
2009 - current
- 1983
Founded Daewoong Chemical
- 1989
Head office relocated
(from Seongnam → Hwaseong,
Hyangnam Pharmaceutical
Management Complex), - 1991
Established corporate research
institute - 1993
Merged with Samwoong Chemical Co., Ltd.
- 1994
Amoxicillin approved by the U.S. FDA
- 1998
First domestic BGMP certification
- 1999
Implemented integrated system
- 1999
SAP R/3; listed on KOSDAQ
- 2003
Obtained ISO 14001 certification
- 2005
Acquired Lilly Korea’s plant
- 2005
Received “Global Excellent Product”
award
(Coenzyme Q10) - 2006
Launched 2nd plant operations
- 2006
Cefuroxime Axetil certified by CEP
(European) - 2007
Acquired Roche Korea’s plant
[now Anseong Plant] - 2008
Ampicillin/Cloxacillin obtained
Japanese PMDA
certification
- 2009
Changed name to Daewoong Bio
- 2009
Commenced operations at
Sichuan Plant in China - 2009
Completed a new plant at
cGMP standards - 2011
Awarded “50 Million Dollar Export
Tower - 2011
Meropenem certified by Japanese
PMDA - 2013
Awarded “70 Million Dollar Export
Tower - 2013
Selected “Best Supplier” by
ABBOTT India - 2013
UDCA certified by CEP (European)
- 2014
Valsartan certified by Japanese PMDA
- 2018
Acquired the cephalosporin business
of Seongnam Plant - 2020
Obtained ISO 37001 certification
- 2023
Selected as a World-Class Company
- 2024
Completed construction of a bio plant
- 2025
Completed construction of a cephalosporin antibiotic plant
Foundation Phase
Recognized for quality excellence worldwide
1980 - 1999
- 1983
Founded Daewoong Chemical
- 1989
Head office relocated
(from Seongnam → Hwaseong,
Hyangnam Pharmaceutical
Management Complex), - 1991
Established corporate research
institute - 1993
Merged with Samwoong Chemical Co., Ltd.
- 1994
Amoxicillin approved by the U.S. FDA
- 1998
First domestic BGMP certification
- 1999
Implemented integrated system
Growth &
Challenge Phase
Stronger competitiveness
through stable production.
2000 - 2008
- 2003
Obtained ISO 14001 certification
- 2005
Acquired Lilly Korea’s plant
- 2005
Received “Global Excellent Product”
award
(Coenzyme Q10) - 2006
Launched 2nd plant operations
- 2006
Cefuroxime Axetil certified by CEP
(European) - 2007
Acquired Roche Korea’s plant
[now Anseong Plant] - 2008
Ampicillin/Cloxacillin obtained
Japanese PMDA
certification
Global Expansion Phase
Evolved into a global health partner.
2009 - current
- 2009
Changed name to Daewoong Bio
- 2009
Commenced operations at
Sichuan Plant in China - 2009
Completed a new plant at
cGMP standards - 2011
Awarded “50 Million Dollar Export
Tower - 2011
Meropenem certified by Japanese
PMDA - 2013
Awarded “70 Million Dollar Export
Tower - 2013
Selected “Best Supplier” by
ABBOTT India - 2013
UDCA certified by CEP (European)
- 2014
Valsartan certified by Japanese PMDA
- 2018
Acquired the cephalosporin business
of Seongnam Plant - 2020
Obtained ISO 37001 certification
- 2023
Selected as a World-Class Company
- 2024
Completed construction of a bio plant
- 2025
Completed construction of a cephalosporin antibiotic plant